27856-10-6

Basic information

• Product Name: Benzenamine, 4-(2,2-dimethylpropyl)-
• CAS NO: 27856-10-6
• Molecular Formula: C11H17N
• Molecular Weight: 163.263
• Mol File: 27856-10-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzenamine, 4-(2,2-dimethylpropyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 4-(2,2-dimethylpropyl)-(27856-10-6)
• EPA Substance Registry System: Benzenamine, 4-(2,2-dimethylpropyl)-(27856-10-6)

Safety Data

• Hazardous Substances Data: 27856-10-6(Hazardous Substances Data)

Upstream product

• 26110-96-3 1-(2,2-dimethylpropyl)-4-nitrobenzene 
• 865471-98-3 1-(2,2-dimethyl-propyl)-2-nitro-benzene 
• 1007-26-7 (2,2-dimethyl-1-propyl)benzene 

Downstream Products

• 267416-68-2 3-Hydroxy-4-methoxy-4'-neopentylpicolinanilide 
• 865471-99-4 3-[4-(2,2-dimethyl-propyl)-phenylamino]-propionic acid ethyl ester 
• 865472-00-0 3-[[4-(2,2-dimethyl-propyl)-phenyl]-(2-ethoxycarbonyl-ethyl)-amino]-propionic acid ethyl ester 
• 861857-51-4 3-bromo-N-[4-(2,2-dimethyl-propyl)-phenyl]-propionamide 
• 95347-95-8 m-Brom-neopentyl-benzol 
• 38896-17-2 N-(4-neopentylphenyl)acetamide 

Relevant articles and documents

-

-

METHODS OF TREATMENT OF AMYLOIDOSIS USING BI-CYCLIC ASPARTYL PROTEASE INHIBITORS

The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS

The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.